PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

45,809 stories, page 663 of 764

Advanced search
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06745024: Comparing Radiation Therapy to Usual Treatment for Patients With High-Risk Bone Metastases That Are Not Causing Pain, PREEMPT Trial

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06463080: [Trial of device that is not approved or cleared by the U.S. FDA]

Study type: . Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06221046: Testing the Safety and Efficacy of a Novel Barrier Cream for the Treatment of Moisture Associated Skin Damage

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06041503: Enfortumab Vedotin With or Without Pembrolizumab in Rare Genitourinary Tumors (E-VIRTUE)

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05848622: Gait Rehabilitation to Treat FastOA

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05742802: Long-term Efficacy and Safety of Tozorakimab in Participants With Chronic Obstructive Pulmonary Disease With a History of Exacerbations (PROSPERO).

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05713071: Evaluation of Bariatric Endoscopic Antral Myotomy (BEAM) as a Treatment for Obesity

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05673200: Testing the Addition of an Anti-cancer Drug, ASTX727 (Cedazuridine, Decitabine), to Chemotherapy (Paclitaxel) and Immunotherapy (Pembrolizumab) for Metastatic Triple-Negative Breast Cancer

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05521854: Contingency Management for Drug Use: Does Age Matter?

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05450250: [Trial of device that is not approved or cleared by the U.S. FDA]

Study type: . Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05277051: First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid Tumors

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05050162: Comparing Cisplatin Every Three Weeks to Cisplatin Weekly When Combined With Radiation for Patients With Advanced Head and Neck Cancer

Study type: INTERVENTIONAL. Phase: PHASE2, PHASE3.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT04573140: A Study of RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM)

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT04321954: Lenvatinib in Locally Advanced Invasive Thyroid Cancer

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Revolution Medicines puts pancreatic cancer combo data on ESMO stage

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Onconic CEO Targets U.S. FDA Phase 3 Filing for Zacuvo This Year

Seoul Economic DailyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Drug maker sues to halt implementation of Arkansas’ new pharmaceutical distribution law

The Arkansas Democrat-GazetteOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

The Challenges Bringing Pharma and Biotech Manufacturing Back to the U.S.

Pharmaceutical ExecutiveOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

What's Driving Amgen's Recent Volatility

Kavout | AIOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Marius Pharmaceuticals backs FDA proposal to revise testosterone therapy warnings

The American BazaarOriginal source
🇺🇸Regulatoryciscrp.orgTier 1 · Regulatory source

Results that Matter: Co-Creating Individual Study Data Reports With Patients

CISCRP Patient InfoOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

News | Australian firm lends boost to Boston biotech market with HQ deal

CoStarOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

HLB rallies as Korea bets on FDA liver cancer decision amid CMC risks - CHOSUNBIZ

ChosunbizOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

At ASMS 2026, mass spectrometry stakes its claim

Drug Discovery NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Firm Advises Underwriters on Legend Biotech’s Public Offering

Wilson SonsiniOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Signs of Recovery in the Biotech Industry

Brownstone ResearchOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Eli Lilly and Abbisko Announce Drug Development Collaboration | PharmExec

Pharmaceutical ExecutiveOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

HHS Proposes Clinical Trial Reform To Catch Chinese Biotech Sector

Foundation for Defense of DemocraciesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

BIO 2026: CEO Calls for U.S. Biotech Urgency and International Competitiveness

Genetic Engineering and Biotechnology NewsOriginal source
🇺🇸Industrycryoport.comTier 1 · Company source

Now Available On Demand: Preventing Advanced Therapy Program Delays with Early Supply Chain Strategy

CryoportOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Restaurant menus must have calorie & allergen info: Maharashtra FDA

The Times of IndiaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

SELLAS Life Sciences Group (SLS) Looks Pricey Following Phase 3 REGAL Trial Progress

simplywall.stOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA Must Reinstate Safety Restrictions for Abortion Drug

lc.orgOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

The biotech bi-weekly: partnerships facilitating antibody discovery and AI drug development

BioTechniquesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Restaurant license suspended | Cheese analogue sold as paneer: Pune FDA launches crackdown

The Indian ExpressOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

How a Drug With More Negative Than Positive Studies Won FDA Approval

MedPage TodayOriginal source
🌍Regulatorywho.intTier 1 · Regulatory source

Yellow fever - Global

WHO Disease Outbreak NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

LLY stock down as FDA asks for more safety data on oral obesity pill

MSNOriginal source
🌍Researchopenclinica.comTier 2 · Direct publisher

Recruiting for the Hard Cases: How UC San Diego Met Every NIH Milestone for a Treatment-Resistant Depression Study

OpenClinicaOriginal source
🇺🇸Researchatlasventure.comTier 2 · Direct publisher

Novartis targets undruggable cancers with $1.9bn Antares Therapeutics deal

Atlas VentureOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Chemical explosion, fire reported at Rockland County pharmaceutical facility

LohudOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA Approves Palbociclib for HR+/HER2+ Metastatic Breast Cancer Maintenance

Oncology Nursing NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Pfizer Advances New Pediatric Pneumococcal “Catch-Up” Vaccine in Phase 3 Trial

TipRanksOriginal source
🇺🇸Industrybiomarin.comTier 1 · Company source

From Unexpected Turns to Purposeful Impact

BioMarin PharmaceuticalOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

DFTX Stock Soars After Phase 3 Depression Trial Win

StocksToTradeOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Explosion happens in pharmaceutical building in Rockland County

CBS NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Moulton pledges investments in biotech, affordable housing

Cambridge DayOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Mycobacterium chimaera: infections linked to heater cooler units

Guidance for healthcare professionals on infection control and clinical aspects of M. chimaera infec...

UK Health Security AgencyOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Foreign Secretary announces support for Gaza with new child medical evacuations and assistance to Palestinians going to top UK universities

The UK will support Gazan students to take up places at British universities and continue efforts to...

UK Department of Health and Social CareOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Semaglutide Surge Associated With Spike in Poison Control Calls

Technology NetworksOriginal source
🌍discoverynews.google.comTier 2 · Trade media

A dispatch on AI from BIOtech’s big summer bash

statnews.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA Must Reinstate Safety Restrictions for Abortion Drug

lc.orgOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA Complete Response Letter (CRL) Explained: What It Means For Biotech Stocks

RTTNewsOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Physician Views Preview: Sanofi secures European approval for tolebrutinib in underserved MS population

FirstWord PharmaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

What Parents Should Know About Generic Drugs

MedShadow FoundationOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA Drug Approval Standards: Can 2 Wins Erase 11 Losses?

The People's PharmacyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Haisco and Nuvectis sign licensing deal for two drugs

Pharmaceutical Business review -Original source
🌍discoverynews.google.comTier 3 · Aggregated media

West Pharmaceutical Services stock hits 52-week high at $338.73

Investing.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

News | Pharmaceutical giant plans more than $1 billion expansion in Jacksonville, Florida

CoStarOriginal source
🌍discoverynews.google.comTier 2 · Trade media

At BIO, a glimpse behind Lilly and Chai’s partnership

statnews.comOriginal source